Accepted at 10:46 a.m. Nov, 23, 2024 by zarathustra
Author: wangbrian99
Co-authors: zarathustra
Related Note: 1523999902660
Rationale for change

added clue to cloze to differentiate its ability to intercalate/bind DNA as well as binding topoisomerase II

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy

Watch Cytotoxic Antibiotics
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize

Physeo
Empty field
Bootcamp
Empty field
OME

Additional Resources
One by one
Empty field
#AK_Step1_v12::#OME::02_The_Cell::03_Inflammation_Neoplasia::08_Cell_Cycle_Chemotherapy #AK_Original_Decks::Step_1::Lolnotacop::Drugs #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::09_Cancer_therapy-targets #AK_Step1_v12::#OME::PreClinical::02_The_Cell::03_Inflammation_Neoplasia::08_Cell_Cycle_Chemotherapy #AK_Step1_v12::#SketchyPharm::08_Antineoplastics::02_DNA_&_Cellular_Division::03_Cytotoxic_Antibiotics #AK_Step1_v12::#Pixorize::03_Pharmacology::12_Oncology_Pharm::03_Doxorubicin/Daunorubicin #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::11_Antitumor_antibiotics::*Anthracyclines !AK_UpdateTags::Step1decks::Lolnotacop::Drugs #AK_Step1_v12::#B&B::11_Hematology::04_Cancer_Drugs::03_Antitumor_Antibiotics